Elite Pharmaceuticals Inc (QB) (ELTP) News

Any one have Tev* in there portfolio? TIA

Just my opinion
Why would a person claim to buy millions of eltp shares, 6 to 10 millions of shares at a price of .03-.05 and sell them at .15?
That person is a liar. To risk 300k to 500k dollars for 3 to 5 cent stock is one thing, to sell them all at .15 is another. Why take a humungous gamble, because he believed in this company. But selling every single share is not logical, unless his belief had suddenly changed. But he knew everything about the company up to 2023. So the obvious reason is he never owned any shares and he’s just a liar making up his stories.
I own many shares of eltp and I sell and buy shares from time to time, but I will never sell out all of my shares because the price is to low and I waited to long. The potential growth is just starting and the future of Elite Phrama is shining bright.

Just my opinion. When / if elite does buy the adderall back from MIKAH, it will be because the volume is drying up and moving to vyvance. So the question for me is would a neutral Elite CEO even consider the purchase. This whole MIkAH thing really bothers me as it’s obvious that Nasrat / MIKAH had the money to make the purchase from Sungen. Why nit just lend the money to elite at one of those sweet 10% interest deals. Whose best interest was the CEO looking out for. Was it MIKAH, Elite , Nasrat , shareholders. Just seems wrong but again, just my opinion.

Which year, 👸 ?????????????????

$1.00 by the end of 2024 is BS time,

IB_🤴

Maybe after next ER.

We are closing in the red apparently

Had a little humor to add..but not today.......Anyway, Merry Christmas and GO TRUMP...(Happy New Year and GO TRUMP are synonymous)

It's going the wrong way for that fantasy

JMO. . .

There is only a week left in the year. I don’t see that happening yet.

Hi NASDAQ2020, you need to put an x next to number 30

EOY $1.00

Toppin off for THE LAUNCH !

ELTP Catalysts:
Next 1-day to 6 months

X 1. Cash Flow Positive - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million IMS market Approved and Launched
X 4. Adderall XR $1.56 Billion IMS market Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. Create in house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement - January 1st 2024
X 8. First shipment Adderall XR to Prasco/Burel Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic OxyContin - FIRST TO FILE FDA Aug 17, 2023 $720 Million
X 11. Generic Vyvanse - $4.7 BILLION - FDA submission Dec 2023
X 12. FDA Acceptance of Generic OxyContin Sept 2023
X 13. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
__14. Dopamine Agonist Approval (probably Requip XL or Mirapex ER). $12 Million
__15. Obtain Full ownership of Adderall IR $ 335 Million from MIKAH
__16. Obtain Full ownership of Adderall XR $ 1.56 Billion from MIKAH
X 17. Vigabatrin Approval $233 Million
X 18. Pyros Vigabatrin -settle VigPoder trade mark challenge and LAUNCH
X 19. Generic Methotrexate Antimetabolite- Approval
X 20. Launch generic Methotrexate $63.4 Million
X 21. $50+ million in yearly revenues
X 22. Lowest PE ratio for OTC Healthcare sector
X 23. Become the ONLY company showing rapid growth on the OTC while being profitable
X 24. Put Opioids back on the Table- due to reduced risk of opioid litigation
X 25. Receive Analyst Coverage - Upgrade to Market Outperform - Zacks Investment Research
__26. Generate revenues over $20 million/quarter
__27. Final Approval of New Manufacturing Facility/Expansion
__28. Double output of manufacturing and packaging facilities
X 29. Launch approved generic Tylenol with Codeine $47 Million
__30. Launch approved generic Norco - hydrocodone acetaminophen IMS $477 Million
__31. Launch approved generic Percocet - oxycodone acetaminophen IMS $500 Million
__32. Launch approved generic Dolophine - methadone HCL tablets IMS $30 Million
X 33. Godzilla -Generic Vyvanse Approval $4.3 Billion
__34. Positive BE Study for Concerta CNS Stimulant $1.2 Billion
__35. Godzilla - Generic Vyvance LAUNCH $4.3 Billion
__36. Generic Concerta- FDA submission $1.2 Billion
__37. $100 million in yearly revenues
__38. Generic OxyContin Tentative Approval $720 Million
__39. Elite prevail over Purdue in Generic OxyContin infringement suit - second 6 month stay - active Accord/Purdue suit causing delay
__40. Launch generic OxyContin $720 Million
__41. Positive BE on NDA Unique ADF opioid - 90% cheaper than ADF without Naltrexone - Game Over Drug
__42. Resume R&D on SequestOx Abuse Deterrent Oxycodone
X 43. International Distribution - partnership Approval by Israeli Ministry of Health for European distribution License and Distribution Agreement by and between Elite Pharmaceuticals, Inc. and Dexcel Ltd.
X 44. Generic IR Adderall® Receives Marketing Approval From The Israeli Ministry Of Health Oct 2024
__45. $200 million in yearly revenue
__46. Patented NDA Unique ADF (w/o naltrexone) drug C in SequestOx reformulation trial
__47. Undisclosed Mikah ANDA(s)
__48. Undisclosed ANDAs/NDAs
__49. Generic Concerta Launch $1.2 Billion
__50. DollarLand PPS
__51. Big Pharma bidding
__52. UpList to the NASDAQ Exchange
__53. ELTP Elite Pharmaceutical Buyout - 2 1/2 years or less from Feb 2024
__54. Vegas BABY !!!!!

Sorry..not with Mikah in the mix, that is a stone cold show stopper. Can't dispute it so don't try.
This will float in the ocean of mediocrity untill
Mikah is gone., the Rat knows this, and so do the
cheerleaders.

This is why their will be no uplisting to NASDAQ. OTC is the wild wild west and you can do whatever you want. No one see's thru this, but don't worry a buy out is coming at $3 a share. LMAO. Next round of kool aide is on me! 😉

Merry Christmas folks! Vyvanse launch imminent.

$ELTP$

Just my opinion. Why would a person that sold millions of shares at.15, I mean all of their shares at .15, still care about the same stock? Now the stock which is eltp is at .55 and he must be mad as hell. So, this person is a disgruntled individual that will say anything on this message board to scare other shareholders into selling their shares. Merry Christmas Jammy

Just my opinion
Nasrat had insight of ceo of elite when he decided as ceo of MIKAH to buy out sungen. He’s made some big bucks

Now he has insight of CEO as elite that adderall will be replaced by vynance so what does he do as ceo of MIKAH , he asks the elite ceo to buy MIKAH out

See how messed up this. it’s not illegal , but it sure as hell should be. Conflict of interest. No problem. Insider knowledge to trends. No big deal. Optics - terrible

Anyways , just my opinion.

It's Merry Christmas !!!!!!!!!!!!!!!!

IB_⛪️

Back at you!!! Merry $$$$$MAS, looking for 2025 to be a much merrier $$$$$$$$$MAS for the ELITE faithful. Still not too late to hitch your wagon back on as done by one of our long time favorites " The SNUP"!!!

MERRY. XMAS every one
Today is half day for the markets

HAPPY HOLLIDAYS

Ah yes, VOG, as memory serves me, volcano fog, very danderious

Not yet...all currently being contained inside the Halemaumau caldera in the Kilauea Volcano Crater. No threats other than vog...

Thx, and a Merry Xmas to you too,
Looks like they are getting ready for some new beach front property

At a million dollars a lot. Lol

This is how we celebrate the holidays on the islands...

Amen

Mele Kalikimaka me ka Hau'oli Makahiki Hou

You don't know !!!!!!!!!!!!!

IB_🤴

Ridgeline Minerals Corp
(RDG)

Bonnes fetes de fin d'annee Jour

I wouldn't count that as analyst coverage. They don't have a buy side. It's just marketing for them. It's better than nothing, but not real analyst coverage. 

I know he don’t have many shares talkin like that.
If I worried about his bs i could never have accumulated millions of shares.

WE did have Zacks !!!

Not to say it couldn't happen, but I've never seen an analyst cover a stock on the OTC. Sell side analysts write their reports for the buy side of the business.

Elite will have a PR very soon. I’m betting next week, the week after at the latest. I also very much want to see a BE announced in Jan. That will give us plenty of push into FY 25 Q3 revenue in mid-Feb.

We are also over due for a mainstream article on the companies ongoing and future growth. I would love for an analyst to start following it.

I feel like the guys on their surfboard waiting for the big wave

Totally agree, think very, very possible a week from today to announce the launch!!!! 😎

It might be good to wait till after Xmas to put out a press release

Elite didn't have a PR today. If you're referring to another stock, keep it off this board. 

I think we move up from hear. The product is finally in a human and their monthly updates should keep investors glued and inspired. I wouldn't want to be on sidelines waiting for first data to be released. We already seen incredible results from animal side. We are finally there. 2025 should be a great year for both tickers.


ELTP
RDG?

Yes, you are now set up very nicely, but you may have to wait a while for the big payoff. I doubt anything big will happen until the trial is over and the publication is out. Hopefully that is in a very highly regarded publication (like JAMA). That could be a full year away (trial wraps up by summer and then it takes a few months to write a paper and a few months for it to be published). I believe how much attention the trial gets at that point of publication will be key. That is when new medical treatments can get into the mainstream news. In the meantime, fankly, I expect to lose money on the investment I took out today. At least until trial results are in, but I hope I'm wrong. Data can be fed to FDA in the meantime so maybe a movement on trials here in the U.S, but then those would have to be paid for. Investing in OTC is a lot of waiting.

Thankfully the wait here at Elite is very close to being over. Worst case here is 6 months for a full quarter of revenue of Vyvanse to be recognized.

Good to hear you made bank and can enjoy your fruit now. Lots going on over there and Doc in coming week or months has ample more info to share in my opinion. They been dormant on X for a long while.

Im still heavy in over there and light here. So a win win is in order.

ELTP

Young company, there is no financials. Financials are not what you gamble on always. At least not for me anyways. Know what you own and why.

Best read or reread todays PR.

That is awesome! I thought I had seen the trials were going to be Indonesia. India is a much better location. If your wondering I'm not unhappy with my decision to divest and move everything to here. I did re-take a small position today to motivate me to keep an eye on it. Nothing like my old position because I am tired of 'waiting' to make money. I have made a bunch and I am now focused on setting myself up to enjoy it! I may add on in 2025 depending on its share price, but again never a large position again unless price tanks for some unjust reason....and I hope it doesn't do that. The longs over there have been put through the wringer! The need to try to get a real news article once the results are in. Nasrat will never do an interview but Korenko has done a few so that is a possibility.

Each % of the Vyvanse market share is equal almost to 2023 annual revenue….

Wake up !!

So reading and interpreting financials is a challenge?

Ok, hope it works out for you. Hell, I'll even check it out.

I have an order in to buy 4000 shares at .5405, then will buy if the price can come down further. Then I have another order in at .5367. Then down further to it hits the gap at .52
Wish me luck everyone.

I already have a mining play Hycroft

Many companies get approvals and get stuck as it takes time to monetize the approval. In our case, Vyvanse is going to have company transforming revenues as the Sales, Manufacturing and Distribution are ready to go. Results will be seen in the quarter following the launch.

Cheers - Happy Holidays